Patient Reported Outcomes from Pharmacist-Led Multiple Sclerosis Assessments in a Specialty Pharmacy Setting
Background: Disease-modifying therapy (DMT) has demonstrated benefits for patients in reducing relapse rates, disability progression, and...
Health and Wellness Needs Reported to Influence Quality of Life in People with Relapsing-Remitting Multiple Sclerosis, a Qualitative Investigation
Background: Multiple sclerosis (MS) is a chronic progressive neurological disease diagnosed commonly between 20-50 years of age, with over...
Direct Cost Associated with Multiple Sclerosis and Important Components; A Population-Based Study 1997-2017
Direct cost associated with Multiple sclerosis: A Population-Based Study 1997-2017 Background: Multiple sclerosis (MS) is a chronic...
An Update on Participants in the Iconquerms Network.
Background: iConquerMS is a multiple sclerosis (MS) participant-powered research network (PPRN), dedicated to engaging people affected by...
Fatigue Evolution for Patients without Relapses on the Fsiq-RMS Symptoms Domain
Background: Multiple sclerosis (MS) is a chronic, demyelinating disease of the central nervous system that results in progressive and...
Improving Health Outcomes of MS Patients during the Pandemic
Background: Living with MS has been particularly challenging during the pandemic; from the emotional and physical toll, to fears about...